U. B. Schaad

3.1k total citations
59 papers, 2.3k citations indexed

About

U. B. Schaad is a scholar working on Epidemiology, Microbiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, U. B. Schaad has authored 59 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Epidemiology, 17 papers in Microbiology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in U. B. Schaad's work include Pneumonia and Respiratory Infections (16 papers), Bacterial Infections and Vaccines (14 papers) and Antibiotics Pharmacokinetics and Efficacy (13 papers). U. B. Schaad is often cited by papers focused on Pneumonia and Respiratory Infections (16 papers), Bacterial Infections and Vaccines (14 papers) and Antibiotics Pharmacokinetics and Efficacy (13 papers). U. B. Schaad collaborates with scholars based in Switzerland, United States and Germany. U. B. Schaad's co-authors include J Wedgwood, S. Suter, F. A. Waldvogel, Stephen L. Leib, David Leppert, Daniel Desgrandchamps, Caroline Grygar, Georg A. Holländer, Karen Miller and K. Stoeckel and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and FEBS Letters.

In The Last Decade

U. B. Schaad

58 papers receiving 2.2k citations

Peers

Countries citing papers authored by U. B. Schaad

Since Specialization

Citations

This map shows the geographic impact of U. B. Schaad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. B. Schaad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. B. Schaad more than expected).

Fields of papers citing papers by U. B. Schaad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U. B. Schaad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. B. Schaad. The network helps show where U. B. Schaad may publish in the future.

Co-authorship network of co-authors of U. B. Schaad

This figure shows the co-authorship network connecting the top 25 collaborators of U. B. Schaad. A scholar is included among the top collaborators of U. B. Schaad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U. B. Schaad. U. B. Schaad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cytokine kinetic profiles in children with acute lower respiratory tract infection: a post hoc descriptive analysis from a randomized control trial 2018 ·Clinical Microbiology and Infection ·Aline Fuchs, Verena Gotta, (unknown), Gabor Szinnai, Philipp Baumann, Jan Bonhoeffer, Nicole Ritz, Gurli Baer, (unknown), Michael Buettcher, (unknown), Ulrich Heininger, Beat Müeller, U. B. Schaad, Philipp Schüetz, Daniel Trachsel	16
2	Clinical Evaluation of an Octavalent Pseudomonas aeruginosa Conjugate Vaccine in Plasma Donors and in Bone Marrow Transplant and Cystic Fibrosis Patients 2015 ·Antibiotics and chemotherapy/Antibiotica et chemotherapia ·Stanley J. Cryz, (unknown), J U Que, Jerald Sadoff, Malcolm K. Brenner, U. B. Schaad	0
3	Gelatinase B [matrix metalloproteinase (MMP)‐9] and collagenases (MMP‐8/‐13) are upregulated in cerebrospinal fluid during aseptic and bacterial meningitis in children 2006 ·Neuropathology and Applied Neurobiology ·Raija L.P. Lindberg, Timo Sorsa, Taina Tervahartiala, Francine Hoffmann, (unknown), Ludwig Kappos, U. B. Schaad, Stephen L. Leib, David Leppert	29
4	Role of Chlamydia pneumoniae and Mycoplasma pneumoniae as Causative Agents of Community-Acquired Pneumonia in Hospitalised Children and Adolescents 2003 ·European Journal of Clinical Microbiology & Infectious Diseases ·Gurli Baer, (unknown), Marianne Abele‐Horn, U. B. Schaad, Ulrich Heininger	24
5	Matrix Metalloproteinase (MMP)-8 and MMP-9 in Cerebrospinal Fluid during Bacterial Meningitis: Association with Blood-Brain Barrier Damage and Neurological Sequelae 2000 ·Clinical Infectious Diseases ·David Leppert, Stephen L. Leib, Caroline Grygar, Karen Miller, U. B. Schaad, Georg A. Holländer	216
6	Screening for complement deficiency in bacterial meningitis 1997 ·Acta Paediatrica ·T. Ernst, (unknown), Christoph Aebi, U. B. Schaad, M G Bianchetti	6
7	Utilisation des quinolones chez l'enfant et risque articulaire 1996 ·Archives de Pédiatrie ·U. B. Schaad	1
8	Immunization of Noncolonized Cystic Fibrosis Patients against Pseudomonas aeruginosa 1994 ·The Journal of Infectious Diseases ·Stanley J. Cryz, J Wedgwood, Aloïs B. Lang, (unknown), J U Que, E Fürer, U. B. Schaad	30
9	Dexamethasone therapy for bacterial meningitis in children 1993 ·The Lancet ·U. B. Schaad, J Wedgwood, Ulrich Lips, (unknown), I Heinzer, A Blumberg	135
10	Epidemiology of vertically transmitted HIV-1 infection in Switzerland: Results of a nationwide prospective study 1992 ·European Journal of Pediatrics ·Christian Kind, (unknown), Claire‐Anne Wyler, A Calame, Christoph Rudin, U. B. Schaad, Jörg Schüpbach, (unknown), Lionel Perrin, L Matter, (unknown)	41
11	Lack of quinolone-induced arthropathy in children 1992 ·Journal of Antimicrobial Chemotherapy ·U. B. Schaad, J Wedgwood	33
12	Affinity Constants of Naturally Acquired and Vaccine-Induced Anti-Pseudomonas aeruginosa Antibodies in Healthy Adults and Cystic Fibrosis Patients 1992 ·The Journal of Infectious Diseases ·Urs Bruderer, Stanley J. Cryz, U. B. Schaad, (unknown), J U Que, Aloïs B. Lang	44
13	Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis 1991 ·The Lancet ·U. B. Schaad, J Wedgwood, (unknown), Aloïs B. Lang, J U Que, E Fürer, Stanley J. Cryz	68
14	Use of quinolones in pediatrics 1991 ·European Journal of Clinical Microbiology & Infectious Diseases ·U. B. Schaad	44
15	Antipseudomonal therapy in cystic fibrosis: Aztreonam and amikacin versus ceftazidime and amikacin administered intravenously followed by oral ciprofloxacin 1989 ·European Journal of Clinical Microbiology & Infectious Diseases ·U. B. Schaad, (unknown), (unknown), (unknown), Richard Kraemer	36
16	Relation between Tumor Necrosis Factor-alpha and Granulocyte Elastase-α1-Proteinase Inhibitor Complexes in the Plasma of Patients with Cystic Fibrosis 1989 ·American Review of Respiratory Disease ·S. Suter, U. B. Schaad, P Roux‐Lombard, Éric Girardin, Georges E. Grau, (unknown)	82
17	Solubilization of immune precipitates by complement in the absence of properdin or factor D 1988 ·FEBS Letters ·Peter Späth, Manuel Pascual, (unknown), U. B. Schaad, Jürg A. Schifferli	5
18	Fibronectin-Cleaving Activity in Bronchial Secretions of Patients with Cystic Fibrosis 1988 ·The Journal of Infectious Diseases ·(unknown), U. B. Schaad, J.‐J. Morgenthaler, Isabelle Chevallier, (unknown)	42
19	Intravenous immune globulin in symptomatic paediatric human immunodeficiency virus infection 1988 ·European Journal of Pediatrics ·U. B. Schaad, Athos Gianella-Borradori, B.A. Perret, Paul Imbach, A. Morell	22
20	[Antibiotic therapy of bacterial meningitis]. 1984 ·PubMed ·U. B. Schaad	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact